- Country: USA
- Summary: Focused Antibody and DNA Production for CVV Investigation
- UST Ref No: 106750362
- Deadline: 10 Sep 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75D30124Q78087
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
This amendment is re-opening the solicitation to allow for further competition. All quotes shall be due by 3:00 PM EDT on Tuesday September 10, 2024. Additional questions, if any, are due by 3:00 PM EDT on Thursday September 5, 2024.
CDC Influenza Division (ID) is responsible for the development of Candidate Vaccine Viruses (CVV) based on circulating and novel influenza strains. CVVs are reassortant viruses which are used as the starting materials for seasonal and pandemic vaccines. To facilitate the development of CVVs, the CDC uses synthetic genes to transcribe viral genes to produce CVVs. Interactions between viruses and host proteins can elucidate molecular properties of viruses not readily apparent by other means. Expressing proteins from engineered plasmids is the foundation of most downstream assays utilized in this regard.
Accordingly, the Influenza Division requires synthetic genes, produced by de novo synthesis or modifications of existing templates through mutagenesis, and other genetic products to be developed routinely based on the constant changes in the genetic makeup of the circulating and novel viruses. These changes are unpredictable and cannot be identified until the viruses are isolated from patients or infected animals. - Documents:
75D30124Q78087-Amendment-2.pdf
Amendment_00001_RFQ_75D30124Q78087.pdf
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINFocused Antibody and DNA Production for CVV Investigation - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | CENTERS FOR DISEASE CONTROL AND PREVENTION, a Government sector organization in USA, has announced a new tender for Focused Antibody and DNA Production for CVV Investigation. This tender is published on USARFP under UST Ref No: 106750362 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-09-10.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
